Literature DB >> 23073476

miRNA profiling in pancreatic cancer and restoration of chemosensitivity.

Saurabh Singh1, Deepak Chitkara, Virender Kumar, Stephen W Behrman, Ram I Mahato.   

Abstract

Pancreatic cancers relapse due to small but distinct population of cancer stem cells (CSCs) which are in turn regulated by miRNAs. The present study identifies a series of miRNAs which were either upregulated (e.g. miR-146) or downregulated (e.g. miRNA-205, miRNA-7) in gemcitabine resistant MIA PaCa-2 cancer cells and clinical metastatic pancreatic cancer tissues. Gemcitabine resistant MIA PaCa-2 cells possessed distinct ALDH-positive CSC fraction expressing stem cell markers OCT3/4 and CD44 and chemoresistance marker class IIIβ-tubulin (TUBB3) which decreases on transfection with miR-205 resulting in the restoration of chemosensitivity to gemcitabine.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073476     DOI: 10.1016/j.canlet.2012.10.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.

Authors:  Shun Ke; Rui-Chao Li; Jun Lu; Fan-Kai Meng; Yi-Kuan Feng; Ming-Hao Fang
Journal:  Int J Hematol       Date:  2017-04-13       Impact factor: 2.490

Review 2.  miRNA nanotherapeutics for cancer.

Authors:  Aditya Ganju; Sheema Khan; Bilal B Hafeez; Stephen W Behrman; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Drug Discov Today       Date:  2016-11-01       Impact factor: 7.851

3.  Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.

Authors:  Amit Kumar Chaudhary; Goutam Mondal; Virender Kumar; Krishna Kattel; Ram I Mahato
Journal:  Cancer Lett       Date:  2017-05-20       Impact factor: 8.679

Review 4.  miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.

Authors:  Anteneh A Tesfaye; Asfar S Azmi; Philip A Philip
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

Review 5.  Developments in miRNA gene signaling pathways in pancreatic cancer.

Authors:  Christina Vorvis; Marina Koutsioumpa; Dimitrios Iliopoulos
Journal:  Future Oncol       Date:  2016-03-17       Impact factor: 3.404

6.  Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.

Authors:  Tian Yang; Tianjun Chen; Yang Li; Lei Gao; Shuo Zhang; Ting Wang; Mingwei Chen
Journal:  Tumour Biol       Date:  2014-11-29

7.  MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.

Authors:  Zhengyuan Zhao; Juntao Liu; Changlei Wang; Yi Wang; Youguo Jiang; Min Guo
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

8.  Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 9.  MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.

Authors:  Marion Gayral; Sébastien Jo; Naima Hanoun; Alix Vignolle-Vidoni; Hubert Lulka; Yannick Delpu; Aline Meulle; Marlène Dufresne; Marine Humeau; Maël Chalret du Rieu; Barbara Bournet; Janick Sèlves; Rosine Guimbaud; Nicolas Carrère; Louis Buscail; Jérôme Torrisani; Pierre Cordelier
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

10.  Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.

Authors:  Juanjuan Zhao; Kailing Wang; Zhenyuan Liao; Ying Li; Hang Yang; Chao Chen; Y A Zhou; Yijin Tao; Mengmeng Guo; Tao Ren; Lin Xu
Journal:  Mol Clin Oncol       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.